How to use pandas_ta library to build R-Breaker indicatorToday is the first day of 2022. I hereby wish all my friends a smooth transaction in the new year, and your account will be N times profitable.
The reason why I write this article is not to simply introduce the R-Breaker strategy itself. I think many of my friends may have used this strategy for in
0.26CNY
358.46 MCNY
8.16 BCNY
506.72 M
About NORTHEAST PHARMACE
Sector
CEO
Kai Zhou
Headquarters
Shenyang
Website
Employees (FY)
6.21 K
Founded
1993
ISIN
CNE0000009G0
FIGI
BBG000P6F699
Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sale of pharmaceutical products. The firm operates through the following three segments-chemical synthetic API & bio-fermentation API, western medicinal preparation & micro-ecological preparation and medical business distribution. Its products include antibiotics, antiviral, anti-infective, antipyretic analgesic, vitamin & obstetrics series, nervous system, cardiovascular system, digestive system, biological diagnosis, respiratory drugs, food & feed additives, nutraceuticals, nutrition and decontamination products. The company was founded on June 10, 1993 and is headquartered in Shenyang, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 000597 is 4.73 CNY — it has increased by 0.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange NORTHEAST PHARMACE stocks are traded under the ticker 000597.
NORTHEAST PHARMACE is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
000597 stock is 1.50% volatile and has beta coefficient of 1.11. Check out the list of the most volatile stocks — is NORTHEAST PHARMACE there?
Yes, you can track NORTHEAST PHARMACE financials in yearly and quarterly reports right on TradingView.
000597 stock has risen by 6.29% compared to the previous week, the month change is a 1.25% fall, over the last year NORTHEAST PHARMACE has showed a 18.45% decrease.
000597 net income for the last quarter is 138.68 M CNY, while the quarter before that showed 84.89 M CNY of net income which accounts for 63.36% change. Track more NORTHEAST PHARMACE financial stats to get the full picture.
Today NORTHEAST PHARMACE has the market capitalization of 6.32 B, it has increased by 5.64% over the last week.
Yes, 000597 dividends are paid annually. The last dividend per share was 0.10 CNY. As of today, Dividend Yield (TTM)% is 2.12%. Tracking NORTHEAST PHARMACE dividends might help you take more informed decisions.
NORTHEAST PHARMACE dividend yield was 1.87% in 2023, and payout ratio reached 40.00%. The year before the numbers were 1.58% and 38.48% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 000597 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NORTHEAST PHARMACE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 6.21 K employees. See our rating of the largest employees — is NORTHEAST PHARMACE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NORTHEAST PHARMACE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NORTHEAST PHARMACE stock shows the sell signal. See more of NORTHEAST PHARMACE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NORTHEAST PHARMACE EBITDA is 937.29 M CNY, and current EBITDA margin is 11.54%. See more stats in NORTHEAST PHARMACE financial statements.